- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 279/02 - 1,2-ThiazinesHydrogenated 1,2-thiazines
Patent holdings for IPC class C07D 279/02
Total number of patents in this class: 82
10-year publication summary
|
4
|
7
|
7
|
2
|
8
|
2
|
9
|
2
|
6
|
5
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| F. Hoffmann-La Roche AG | 7942 |
6 |
| Genentech, Inc. | 3988 |
6 |
| Vandria SA | 15 |
6 |
| Amgen Inc. | 4097 |
5 |
| Mochida Pharmaceutical Co., Ltd. | 338 |
4 |
| Resverlogix Corp. | 56 |
3 |
| Sunshine Lake Pharma Co., Ltd. | 599 |
3 |
| Samsung Display Co., Ltd. | 35100 |
2 |
| Janssen Pharmaceutica N.V. | 3381 |
2 |
| Merck Patent GmbH | 5820 |
2 |
| Centre National de La Recherche Scientifique | 10498 |
2 |
| Riken | 1695 |
2 |
| Sierra Sciences, LLC | 8 |
2 |
| Universita Degli Studi di Perugia | 43 |
2 |
| Universita degli Studi di Trento | 75 |
2 |
| Universite de Poitiers | 188 |
2 |
| Sorbonne Universite | 1302 |
2 |
| Glaxo Group Limited | 4104 |
1 |
| Novartis AG | 10726 |
1 |
| Syngenta Crop Protection AG | 6100 |
1 |
| Other owners | 26 |